BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu W, Mao SY, Zhu WY. Impact of tiny miRNAs on cancers. World J Gastroenterol 2007; 13(4): 497-502 [PMID: 17278213 DOI: 10.3748/wjg.v13.i4.497]
URL: https://www.wjgnet.com/1007-9327/full/v13/i4/497.htm
Number Citing Articles
1
Yasan Sadeghian, Zahra Kamyabi-Moghaddam, Seyed Mohamad Hossein Tabatabaei Nodushan, Samaneh Khoshbakht, Behnam Pedram, Emad Yahaghi, Aram Mokarizadeh, Mahdi Mohebbi. RETRACTED ARTICLE: Profiles of tissue microRNAs; miR-148b and miR-25 serve as potential prognostic biomarkers for hepatocellular carcinomaTumor Biology 2016; 37(12): 16379 doi: 10.1007/s13277-015-3799-y
2
Ge Yu, Jian-qiang Tang, Mao-lin Tian, Hui Li, Xin Wang, Tao Wu, Jing Zhu, Shan-jun Huang, Yuan-lian Wan. Prognostic values of the miR-17-92 cluster and its paralogs in colon cancerJournal of Surgical Oncology 2012; 106(3): 232 doi: 10.1002/jso.22138
3
Ahmad Mahdian-shakib, Ruhollah Dorostkar, Mahdi Tat, Mohammad Sadegh Hashemzadeh, Navid Saidi. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancerBiomedicine & Pharmacotherapy 2016; 84: 592 doi: 10.1016/j.biopha.2016.09.087
4
Tuan Meng Lee, Leonard Lipovich. Structural differences of orthologous genes: Insights from human–primate comparisonsGenomics 2008; 92(3): 134 doi: 10.1016/j.ygeno.2008.05.006
5
Erin Connolly, Margherita Melegari, Pablo Landgraf, Tatyana Tchaikovskaya, Bud C. Tennant, Betty L. Slagle, Leslie E. Rogler, Mihaela Zavolan, Thomas Tuschl, Charles E. Rogler. Elevated Expression of the miR-17–92 Polycistron and miR-21 in Hepadnavirus-Associated Hepatocellular Carcinoma Contributes to the Malignant PhenotypeThe American Journal of Pathology 2008; 173(3): 856 doi: 10.2353/ajpath.2008.080096
6
Joel Pekow, Katherine Meckel, Urszula Dougherty, Yong Huang, Xindi Chen, Anas Almoghrabi, Reba Mustafi, Fatma Ayaloglu-Butun, Zifeng Deng, Haider I. Haider, John Hart, David T. Rubin, John H. Kwon, Marc Bissonnette. miR-193a-3p is a Key Tumor Suppressor in Ulcerative Colitis–Associated Colon Cancer and Promotes Carcinogenesis through Upregulation of IL17RDClinical Cancer Research 2017; 23(17): 5281 doi: 10.1158/1078-0432.CCR-17-0171
7
Ling Xu, Wei-Qi Dai, Xuan-Fu Xu, Fan Wang, Lei He, Chuan-Yong Guo. Effects of Multiple-target Anti-microRNA Antisense Oligodeoxyribonucleotides on Proliferation and Migration of Gastric Cancer CellsAsian Pacific Journal of Cancer Prevention 2012; 13(7): 3203 doi: 10.7314/APJCP.2012.13.7.3203
8
Masoomeh Dadpay, Mojtaba Zarea, Rahman Ghaffarzadegan Rabati, Bijan Rezakhaniha, Babak Barari, Vahid Behnod, Katayoun Ziari. RETRACTED ARTICLE: Upregulation of miR-21 and downregulation of miR-494 may serve as emerging molecular biomarkers for prediagnostic samples of subjects who developed nasopharyngeal carcinoma associates with lymph node metastasis and poor prognosisTumor Biology 2016; 37(12): 16383 doi: 10.1007/s13277-015-3905-1
9
Junlong Zhang, Xinhua Xiao, Linong Ji. Epigenetic disorder plays a fundamental role in the etiology of type 2 diabetesWuhan University Journal of Natural Sciences 2013; 18(1): 9 doi: 10.1007/s11859-013-0886-z
10
Joel Pekow, Katherine Meckel, Urszula Dougherty, Fatma Butun, Reba Mustafi, John Lim, Charis Crofton, Xindi Chen, Loren Joseph, Marc Bissonnette. Tumor suppressors miR-143 and miR-145 and predicted target proteins API5, ERK5, K-RAS, and IRS-1 are differentially expressed in proximal and distal colonAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2015; 308(3): G179 doi: 10.1152/ajpgi.00208.2014
11
Zhaoji Luan, Baoliang Liu, Lina Shi. Angiotensin II‐induced micro RNA‐21 culprit for non‐small‐cell lung adenocarcinomaDrug Development Research 2019; 80(8): 1031 doi: 10.1002/ddr.21597
12
Yukiharu Hiyoshi, Aaron J. Schetter, Hirokazu Okayama, Kentaro Inamura, Katsuhiro Anami, Giang H. Nguyen, Izumi Horikawa, Jason E. Hawkes, Elise D. Bowman, Suet Yi Leung, Curtis C. Harris, Hong Wang. Increased MicroRNA-34b and -34c Predominantly Expressed in Stromal Tissues Is Associated with Poor Prognosis in Human Colon CancerPLOS ONE 2015; 10(4): e0124899 doi: 10.1371/journal.pone.0124899
13
Ajaz A. Bhat, Salma N. Younes, Syed Shadab Raza, Lubna Zarif, Sabah Nisar, Ikhlak Ahmed, Rashid Mir, Sachin Kumar, Surender K. Sharawat, Sheema Hashem, Imadeldin Elfaki, Michal Kulinski, Shilpa Kuttikrishnan, Kirti S. Prabhu, Abdul Q. Khan, Santosh K. Yadav, Wael El-Rifai, Mohammad A. Zargar, Hatem Zayed, Mohammad Haris, Shahab Uddin. Role of non-coding RNA networks in leukemia progression, metastasis and drug resistanceMolecular Cancer 2020; 19(1) doi: 10.1186/s12943-020-01175-9
14
Zhong-xue Su, Juan Zhao, Zhong-hou Rong, Wen-mao Geng, Ya-guang Wu, Cheng-kun Qin. Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinomaDiagnostic Pathology 2014; 9(1) doi: 10.1186/1746-1596-9-47
15
Joel R. Pekow, Urszula Dougherty, Reba Mustafi, Hongyan Zhu, Masha Kocherginsky, David T. Rubin, Stephen B. Hanauer, John Hart, Eugene B. Chang, Alessandro Fichera, Loren J. Joseph, Marc Bissonnette. miR-143 and miR-145 are downregulated in ulcerative colitis: Putative regulators of inflammation and protooncogenesInflammatory Bowel Diseases 2012; 18(1): 94 doi: 10.1002/ibd.21742
16
Tai-Yue Kuo, Edward Hsi, I-Ping Yang, Pei-Chien Tsai, Jaw-Yuan Wang, Suh-Hang Hank Juo, Steve Horvath. Computational Analysis of mRNA Expression Profiles Identifies MicroRNA-29a/c as Predictor of Colorectal Cancer Early RecurrencePLoS ONE 2012; 7(2): e31587 doi: 10.1371/journal.pone.0031587
17
Mariana Ioniţă, George Mihail Vlăsceanu, Aiza Andreea Watzlawek, Stefan Ioan Voicu, Jorge S. Burns, Horia Iovu. Graphene and functionalized graphene: Extraordinary prospects for nanobiocomposite materialsComposites Part B: Engineering 2017; 121: 34 doi: 10.1016/j.compositesb.2017.03.031
18
Lumin Wang, Jiayi Yao, Hongfei Sun, Kang He, Dongdong Tong, Tusheng Song, Chen Huang. MicroRNA-101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3AOncology Letters 2017; 13(1): 329 doi: 10.3892/ol.2016.5423
19
Jichuan Xu, Jian Xu, Xinyuan Liu, Jianxin Jiang. The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancerCell Death Discovery 2022; 8(1) doi: 10.1038/s41420-022-01061-x
20
Lumin Wang, Jiayi Yao, Xin Shi, Lili Hu, Zongfang Li, Tusheng Song, Chen Huang. MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cellsBMC Cancer 2013; 13(1) doi: 10.1186/1471-2407-13-448
21
Jasdeep Kaur Dhanoa, Ramneek Verma, R. S. Sethi, Jaspreet Singh Arora, C. S. Mukhopadhyay. Biogenesis and biological implications of isomiRs in mammals- a reviewExRNA 2019; 1(1) doi: 10.1186/s41544-018-0003-8
22
Alexandros Ο. Konstantinidis, Dimitra Pardali, Katerina K. Adamama-Moraitou, Maria Gazouli, Chrysostomos I. Dovas, Evangelia Legaki, Georgia D. Brellou, Ioannis Savvas, Albert E. Jergens, Timoleon S. Rallis, Karin Allenspach. Colonic mucosal and serum expression of microRNAs in canine large intestinal inflammatory bowel diseaseBMC Veterinary Research 2020; 16(1) doi: 10.1186/s12917-020-02287-6
23
Lin Liu, Lin Chen, Yingxin Xu, Rong Li, Xiaohui Du. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cellsBiochemical and Biophysical Research Communications 2010; 400(2): 236 doi: 10.1016/j.bbrc.2010.08.046
24
PINGYU WANG, SHUYANG XIE, AIDONG CUI, YANXIANG ZHANG, BAOFA JIANG. miR-196a2 polymorphisms and susceptibility to cancer: A meta-analysis involving 24,697 subjectsExperimental and Therapeutic Medicine 2012; 3(2): 324 doi: 10.3892/etm.2011.399
25
T. V. Shirina, M. T. Bobrovskaya, E. A. Kozlov. MicroRNA: from fundamental research to their applicationBiopolymers and Cell 2007; 23(6): 467 doi: 10.7124/bc.000781
26
Yoshinao Ruike, Atsuhiko Ichimura, Soken Tsuchiya, Kazuharu Shimizu, Ryo Kunimoto, Yasushi Okuno, Gozoh Tsujimoto. Global correlation analysis for micro-RNA and mRNA expression profiles in human cell linesJournal of Human Genetics 2008; 53(6): 515 doi: 10.1007/s10038-008-0279-x
27
Adewale Oluwaseun Fadaka, Ashley Pretorius, Ashwil Klein. Functional Prediction of Candidate MicroRNAs for CRC Management Using in Silico ApproachInternational Journal of Molecular Sciences 2019; 20(20): 5190 doi: 10.3390/ijms20205190
28
Joel R. Pekow, John H. Kwon. MicroRNAs in inflammatory bowel diseaseInflammatory Bowel Diseases 2012; 18(1): 187 doi: 10.1002/ibd.21691
29
Simona Ruxandra Volovat, Constantin Volovat, Irina Hordila, Dorin-Alexandru Hordila, Ciprian Camil Mirestean, Oana Tatiana Miron, Cristian Lungulescu, Dragos Viorel Scripcariu, Cati Raluca Stolniceanu, Assia Adrianova Konsoulova-Kirova, Cristina Grigorescu, Cipriana Stefanescu, Cristian Constantin Volovat, Iolanda Augustin. MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A ReviewFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.526850
30
Shengzhuo Liu, Shijian Feng, Deyi Luo. Analysis of key genes and micro-RNA-mRNA regulatory networks in women with ulcerative interstitial cystitis/pain bladder syndromeInternational Urogynecology Journal 2019; 30(9): 1487 doi: 10.1007/s00192-018-3817-x
31
Xia Wu, Cui Kong, Yilei Wu. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axisBioengineered 2021; 12(1): 9046 doi: 10.1080/21655979.2021.1993715
32
YANG YANG, SU'E CHANG, ZHENGHAO ZHAO, NI HOU, KANG HE, XIAOFEI WANG, LING GAO, LUMIN WANG, DONGHUI CAI, BO GUO, DONGDONG TONG, TUSHENG SONG, CHEN HUANG. MicroRNA-214 suppresses the proliferation of human hepatocellular carcinoma cells by targeting E2F3Oncology Letters 2015; 10(6): 3779 doi: 10.3892/ol.2015.3745
33
Cliff I. Oduor, Yasin Kaymaz, Kiprotich Chelimo, Juliana A. Otieno, John Michael Ong’echa, Ann M. Moormann, Jeffrey A. Bailey. Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphomaBMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3711-9
34
Ernest Osei, Stephanie Swanson, Ruth Francis. Review of novel liquid-based biomarkers for prostate cancer: towards personalised and targeted medicineJournal of Radiotherapy in Practice 2023; 22 doi: 10.1017/S1460396921000248
35
Srilekha Avvari, DKV Prasad, Imran Ali Khan. Role of MicroRNAs in Cancers2022; : 37 doi: 10.1007/978-981-16-9186-7_3
36
Smriti Gupta, Savita Verma, Shrikant Mantri, Nancy E. Berman, Rajat Sandhir. Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative DisordersDrug Development Research 2015; 76(7): 397 doi: 10.1002/ddr.21277
37
Liang Huang, Fei-Yan Deng, Shu-Feng Lei. Global correlation analysis for miRNA and protein expression profiles in human peripheral blood mononuclear cellsMolecular Biology Reports 2020; 47(7): 5295 doi: 10.1007/s11033-020-05608-y
38
Peyman Karimi Goudarzi, Afshin Taheriazam, Saeid Asghari, Mohammad Jamshidi, Mohammadreza Shakeri, Emad Yahaghi, Alireza Mirghasemi. RETRACTED ARTICLE: Downregulation of miR-185 and upregulation of miR-218 expression may be potential diagnostic and prognostic biomarkers of human chondrosarcomaTumor Biology 2016; 37(5): 5775 doi: 10.1007/s13277-015-4090-y
39
Tariq Alzahem, Waleed Alsarhani, Abdullah Albahlal, Leen Abu Safieh, Saad Aldahmash. Retinoblastoma - Past, Present and Future2019;  doi: 10.5772/intechopen.89035
40
Qinggong Yuan, Gang Cao, Junhui Li, Yan Zhang, Wenbin Yang. MicroRNA-136 inhibits colon cancer cell proliferation and invasion through targeting liver receptor homolog-1/Wnt signalingGene 2017; 628: 48 doi: 10.1016/j.gene.2017.07.031
41
Lalita A. Shevde, Brandon J. Metge, Aparna Mitra, Yaguang Xi, Jingfang Ju, Judy A. King, Rajeev S. Samant. Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontinJournal of Cellular and Molecular Medicine 2009; 14(6b): 1693 doi: 10.1111/j.1582-4934.2009.00821.x
42
Yike Fu, Tong Chen, Gang Wang, Tongxu Gu, Congkun Xie, Jie Huang, Xiang Li, Serena Best, Gaorong Han. Production of a fluorescence resonance energy transfer (FRET) biosensor membrane for microRNA detectionJournal of Materials Chemistry B 2017; 5(34): 7133 doi: 10.1039/C7TB01399J